These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8913268)

  • 21. Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-{kappa}B and Mat1A genes in the early stages of rat liver carcinogenesis.
    Simile MM; Pagnan G; Pastorino F; Brignole C; De Miglio MR; Muroni MR; Asara G; Frau M; Seddaiu MA; Calvisi DF; Feo F; Ponzoni M; Pascale RM
    Carcinogenesis; 2005 Feb; 26(2):417-27. PubMed ID: 15498786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel mechanism by which N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell growth: the production of nitric oxide.
    Simeone AM; Ekmekcioglu S; Broemeling LD; Grimm EA; Tari AM
    Mol Cancer Ther; 2002 Oct; 1(12):1009-17. PubMed ID: 12481423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
    Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
    Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing the effect of ATRA, 4-HPR, and CD437 in bladder cancer cells.
    Zou C; Zhou J; Qian L; Feugang JM; Liu J; Wang X; Wu S; Ding H; Zou C; Liebert M; Grossman HB
    Front Biosci; 2006 Sep; 11():2007-16. PubMed ID: 16720286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of cyclophilin gene expression by N-4-(hydroxyphenyl)retinamide: association with reactive oxygen species generation and apoptosis.
    Hursting SD; Shen JC; Sun XY; Wang TT; Phang JM; Perkins SN
    Mol Carcinog; 2002 Jan; 33(1):16-24. PubMed ID: 11807954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells.
    Appierto V; Villani MG; Cavadini E; Gariboldi M; De Cecco L; Pierotti MA; Lambert JR; Reid J; Tiberio P; Colombo N; Formelli F
    Oncogene; 2007 Jun; 26(27):3952-62. PubMed ID: 17213814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclooxygenase-2 is essential for HER2/neu to suppress N- (4-hydroxyphenyl)retinamide apoptotic effects in breast cancer cells.
    Simeone AM; Li YJ; Broemeling LD; Johnson MM; Tuna M; Tari AM
    Cancer Res; 2004 Feb; 64(4):1224-8. PubMed ID: 14973114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 4-HPR Is an Endoplasmic Reticulum Stress Aggravator and Sensitizes Breast Cancer Cells Resistant to TRAIL/Apo2L.
    Anding AL; Jones JD; Newton MA; Curley RW; Clagett-Dame M
    Anticancer Res; 2018 Aug; 38(8):4403-4416. PubMed ID: 30061204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression.
    Xu H; Cheepala S; McCauley E; Coombes K; Xiao L; Fischer SM; Clifford JL
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):969-79. PubMed ID: 16467112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The retinoid fenretinide inhibits proliferation and downregulates cyclooxygenase-2 gene expression in human colon adenocarcinoma cell lines.
    Merritt G; Aliprandis ET; Prada F; Rigas B; Kashfi K
    Cancer Lett; 2001 Mar; 164(1):15-23. PubMed ID: 11166911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells.
    Oridate N; Suzuki S; Higuchi M; Mitchell MF; Hong WK; Lotan R
    J Natl Cancer Inst; 1997 Aug; 89(16):1191-8. PubMed ID: 9274913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining a BCL2 inhibitor with the retinoid derivative fenretinide targets melanoma cells including melanoma initiating cells.
    Mukherjee N; Reuland SN; Lu Y; Luo Y; Lambert K; Fujita M; Robinson WA; Robinson SE; Norris DA; Shellman YG
    J Invest Dermatol; 2015 Mar; 135(3):842-850. PubMed ID: 25350317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
    Ohlmann CH; Jung C; Jaques G
    Int J Cancer; 2002 Aug; 100(5):520-6. PubMed ID: 12124800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 4-HPR-mediated leukemia cell cytotoxicity is triggered by ceramide-induced mitochondrial oxidative stress and is regulated downstream by Bcl-2.
    Morales MC; Pérez-Yarza G; Rementería NN; Boyano MD; Apraiz A; Gómez-Muñoz A; Pérez-Andrés E; Asumendi A
    Free Radic Res; 2007 May; 41(5):591-601. PubMed ID: 17454142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of caspase-8 during N-(4-hydroxyphenyl)retinamide-induced apoptosis in Fas-defective hepatoma cells.
    You KR; Shin MN; Park RK; Lee SO; Kim DG
    Hepatology; 2001 Dec; 34(6):1119-27. PubMed ID: 11732001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of chemotherapeutic agents on the Bcl-2/Bax apoptosis pathway in human breast cancer cell line MCF-7.
    Leung LK; Wang TT
    Breast Cancer Res Treat; 1999 May; 55(1):73-83. PubMed ID: 10472781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of lipocalin-2 gene by the cancer chemopreventive retinoid 4-HPR.
    Caramuta S; De Cecco L; Reid JF; Zannini L; Gariboldi M; Kjeldsen L; Pierotti MA; Delia D
    Int J Cancer; 2006 Oct; 119(7):1599-606. PubMed ID: 16671099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BAG-1 promotes apoptosis induced by N-(4-hydroxyphenyl)retinamide in human cervical carcinoma cells.
    Yang X; Hao Y; Ding Z; Pater A
    Exp Cell Res; 2000 May; 256(2):491-9. PubMed ID: 10772821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells.
    Simeone AM; Colella S; Krahe R; Johnson MM; Mora E; Tari AM
    Carcinogenesis; 2006 Mar; 27(3):568-77. PubMed ID: 16199439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells.
    Appierto V; Villani MG; Cavadini E; Lotan R; Vinson C; Formelli F
    Cell Death Differ; 2004 Mar; 11(3):270-9. PubMed ID: 14647238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.